touchPODCAST

touchEXPERT FOCUS for touchENDOCRINOLOGY Listen to a series of interviews with Dr. Eden Miller who will provide her expert insights into the recognition of typical and euglycemic diabetic ketoacidosis (DKA), the current and emerging ketone monitoring methods, including continuous ketone monitoring and the importance of optimizing patient and caregiver education to reduce preventable DKA events and...

touchCASES for touchONCOLOGY Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.      The experts: Dr Nicoletta Colombo, European Institute of Oncology, Milan, Italy Dr Ilaria Colombo, Oncolog...

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with a leading expert in cataract surgery. Dr Filomena Ribeiro shares insights on the latest advances in pre-operative assessment, AI-enhanced IOL power calculation and functional depth-of-field (DOFi)-based lens selection, as well as emerging IOL materials and technologies. She also provides practical guidance on pati...

touchCASES for touchNEUROLOGY Listen to two US-based experts as they discuss how to improve diagnostic accuracy in the USA for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). They will discuss three patient cases to illustrate how to recognize and differentiate CIDP variants from other polyneuropathies, and apply key diagnostic criteria to help strengthen a diagnosis. The e...

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with Dr. Diana Do as she shares her expert insights into the epidemiology and quality‑of‑life burden of diabetic macular edema (DME) in the USA, outlines real‑world limitations of current anti‑VEGF–based management, and examines emerging therapies that specifically target blood–retinal barrier (BRB) dysfunction and aim to pr...

touchTALKS for touchONCOLOGY Listen to Dr Teresa Alonso-Gordoa, as she evaluates the latest data on dual EZH2/AR inhibition in mCRPC and explores how emerging evidence could influence clinical decision-making in the future. The expert Dr. Teresa Alonso-Gordoa - Hospital Universitario Ramón y Cajal, Madrid, Spain This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an in...

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with three leading experts discussing neural-targeted therapies for dry eye disease (DED). The faculty describe the neuronal control of tear secretion, explore the mechanisms of action and clinical findings with neuromodulatory/neurostimulatory therapies for DED, and discuss how to integrate these therapies into person...

touchEXPERT FOCUS for touchONCOLOGY and touchRESPIRATORY   Listen to a series of short interviews with leading experts on computational pathology in NSCLC. The faculty, an oncologist, an oncologist-researcher and a pathologist, discuss the clinical value of computational pathology in NSCLC, review emerging tools and share practical insights on how these approaches can be applied in routine patient...

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the future of care for patients with pancreatic ductal adenocarcinoma, or PDAC.  The faculty provide their insights on the current unmet needs, the evolving role of imaging, biomarker testing, and treatment strategies, and how these developments may impact clinical care. The experts: Dr Eileen O'Reilly - Memorial...

touchEXPERT FOCUS for touchOPHTHALMOLOGY   Listen to a series of interviews with Dr Maria-João Menéres who will provide her expert insights into the mechanisms of retinal ganglion cell (RGC) damage in both primary open-angle and secondary, steroid-induced glaucoma, and the importance of neuroprotection to mitigate the risk of glaucoma development or progression. The expert: Dr Maria-João Menéres,...

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen as Prof. Sumit (Sam) Garg shares expert clinical insights on how AI-supported biometric analysis can increase refractive accuracy and support confident presbyopia-correcting IOL selection, including which patient and ocular characteristics are most likely to benefit from AI-based tools. He also outlines practical strategies for structuring preoperati...

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY Listen to leading experts discuss guideline-directed strategies for mutational analysis and monitoring response when treating patients with chronic-phase chronic myeloid leukaemia with approved tyrosine kinase inhibitors. The experts Dr Jorge Cortes, Georgia Cancer Center, Augusta, GA, USA Dr Elias Jabbour, MD Anderson Cancer Center, Hou...

touchEXPERT FOCUS for touchENDOCRINOLOGY Listen to a series of short interviews with paediatric endocrinologist Dr Ashley Shoemaker as she discusses the clinical manifestations and pathophysiology of Prader–Willi syndrome (PWS), with a focus on hyperphagia by exploring the spectrum across the lifespan of PWS and shares best practices for managing PWS-related hyperphagia within a multidisciplinary...

touchPANEL DISCUSSION for touchONCOLOGY and touchRESPIRATORY   Listen to leading experts discuss the role of antibody–drug conjugates (ADCs) in NSCLC with brain metastases, including the latest clinical trial evidence, practical approaches to patient selection and treatment sequencing alongside local CNS therapies, and the evolving pipeline of investigational ADCs. The expert(s) Dr Lyudmila Bazhen...

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY Listen to a panel of leading experts as they explore the latest advances in PNH pathophysiology, diagnostic approaches and therapeutic strategies, including data from ASH 2025, with practical insights for contemporary clinical practice. The experts: Prof. Bruno Fattizzo, Università degli Studi di Milano, Milan, Italy Dr Austin Kulasekara...

touchCASES for touchNEUROLOGY, touchCARDIO, touchENDOCRINOLOGY and touchRESPIRATORY Listen to two experts as they discuss three cases illustrating the heterogeneous, multisystem nature of late-onset Pompe disease (LOPD). They examine key decision points from recognizing early clinical clues and confirming diagnosis to optimizing enzyme replacement therapy (ERT), monitoring progression and coordina...

touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Dr Rakesh Popat review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the International Multiple Society (IMS) and American Society of Hematology (ASH) 2025 congresses. Dr Popat is then joined by fellow experts Dr Paula Rodríguez-Otero and Dr Roberto Mina...

touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging...

touchEXPERT FOCUS for touchONCOLOGY Listen to insights from Dr Kathleen Moore on the pathophysiology and molecular features of low-grade serous ovarian cancer (LGSOC) and how it differs from other ovarian cancers. She also discusses evidence-based treatment options and sequencing, as well as practical considerations relating to administration and side-effect management. The expert: Dr Kathleen Moo...

touchIN CONVERSATION for touchHAEMATOLOGY The presence of anaemia and/or thrombocytopenia complicates the management of patients with myelofibrosis (MF). Listen to expert haematologists consider the burden of cytopenias in patients with MF and discuss strategies to reduce transfusion dependence, improve splenomegaly and personalize treatment with JAK inhibitors. The experts Prof. Claire Harrison,...

touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY Listen to a series of short interviews with three leading experts who provide their insights into early-line management of chronic myeloid leukaemia and the impact on quality of life. The experts: Dr Delphine Rea, Hôpital Saint-Louis, Paris, France  Prof. Andreas Hochhaus, Jena University Hospital, Jena, Germany Prof. Etab Atallah, Medical C...

touchTALKS for touchONCOLOGY Listen to Dr Christine Bestvina, as she evaluates the latest data on KRAS mutations in NSCLC and explores how emerging evidence for targeted therapies could influence clinical decision-making. The expert Dr Christine Bestvina, University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical educa...

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with four leading experts as they discuss the role of HER2 as a targetable biomarker in BTC and GEA. They examine the present treatment landscape for HER2-positive BTC and GEA and evaluate clinical implications of recent approvals and advances in current and emerging HER2-targeting therapies for HER2-positive BTC and GEA. ...

touchPANEL DISCUSSION for touchONCOLOGY and touchENDOCRINOLOGY Listen to a panel of leading experts discuss the optimal management of gastroenteropancreatic neuroendocrine tumours (GEP-NETs), with a focus on peptide receptor radionuclide therapy (PRRT). The faculty provide their insights on the current state of the art, the evolving role of PRRT in GEP-NET treatment, and recent data with existing...

touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging...